HOLLY CHITWOOD: Open Payments
NPI 1639536972 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,441 in 15 payments from 9 companies in 2025. Trend: 2023 $2,888 · 2024 $1,290 · 2025 $1,441
Food & beverage: $1,441
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 4 | $402 |
| Merck Sharp & Dohme LLC | 4 | $274 |
| Astellas Pharma US Inc | 1 | $139 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| BTG International Inc. | 1 | $125 |
| Amgen Inc. | 1 | $107 |
| Daiichi Sankyo Inc. | 1 | $104 |
| Novo Nordisk Inc | 1 | $102 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $62 |
Products named: ZIIHERA, KEYTRUDA, Padcev, JEMPERLI, VORAXAZE, ZEPZELCA, IMDELLTRA (AMG757), Enhertu.
Industry payments across KY — which companies pay providers there.
